Navigation Links
Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
Date:11/9/2010

-$   261,549Research and development

(738,014)(1,176,942)(1,871,175)(3,528,249)Selling, general and administrative

(1,083,066)(1,309,332)(3,402,561)(3,819,473)Loss from operations

(1,821,080)(2,250,357)(5,273,736)(7,086,173)Interest income (expense), net

9,049(1,335,511)24,585(5,878.853)Change in fair value of derivative liabilities

(1,636,700)1,964,66370,280(12,509,518)Loss from continuing operations

(3,448,731)(1,621,205)(5,178,871)(25,474,544)Income (loss) from discontinued operations

-95,576-(1,930,636)Gain on sale of business unit

-6,408,603-6,408,603Net income (loss)

$
(3,448,731)$   4,882,974$ (5,178,871)$(20,996,577)Net loss per common  share – basic and diluted

$
(0.04)$
.10$
(0.07)$
(0.44)Weighted average common shares outstanding  – basic

77,852,15447,771,60971,956,29847,214,142Weighted average common shares outstanding  – diluted

77,852,15449,629,07971,956,29847,214,142Cardium Therapeutics, Inc.Reconciliation of Non-GAAP MeasureAs of September 30, 2010Three months ended September 30,Nine months ended September 30,2010200920102009Net  income (loss)

$
(3,448,731)$   4,882,974$(5,178,871)$(20,996,577)Add (subtract)Stock based compensation expense

80,337124,129315,129494,750Amortization of deferred financing cost and debt discount

-1,085,678-4,903,078Change in fair value of derivative liabilities

1,636,700(1,964,663)(70,280)12,509,518Income (loss) from discontinued operations

-(95,576)-1,930,636Gain on sale of business unit

-(6,408,603)-(6,408,603)Non-GAAP net loss

$
(1,731,694)$
(2,376,061)$   (4,934,022)$
(7,567,198)Non-GAAP net loss per common  share – basic and diluted

$
(0.02)$
(0.05)$
(0.07)$
(0.16)Weighted average common shares outstanding  – basic

77,852,15447,771,60971,956,29847,214,1
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
2. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
3. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
4. Cardium Regains Listing Compliance With NYSE Amex
5. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
6. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
7. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
8. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
9. Cardium Completes $6.0 Million Registered Direct Offering
10. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
11. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Green & Grow Inc. (GGI) has raised ... secured Otter Capital as a significant new partner. Otter ... GGI’s Agriplier™ technology, building on recent compelling field trial ... first meeting, we have been impressed with Otter Capital’s ... Alan Sobba, President and CEO of GGI. “We look ...
(Date:8/27/2014)... California (PRWEB) August 27, 2014 ... (LLNL), through Lawrence Livermore National Security LLC ... to develop and deliver a state-of-the-art laser system ... facility (ELI Beamlines), under construction in the Czech ... performance, the laser system, called the " High ...
(Date:8/27/2014)... DENVER , Aug. 27, 2014   MSC ... and patient safety, today announced the appointment of ... With 28 years of experience preparing companies ... in 2013 as Executive Vice President of Corporate Development ... healthcare performance improvement business , as well as corporate ...
(Date:8/27/2014)... 27, 2014 The Global and China ... on the current state of the Trifluoroacetic Acid industry ... basic overview of the industry, including definitions, applications and ... market analysis are provided with a focus on history, ... comparison between the international and Chinese situation is also ...
Breaking Biology Technology:Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3MSC names Mary Beth Loesch President and CEO 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, ... are as follows:   , , , ... , Time:  8:30am Pacific Time , ... Location: The Ritz-Carlton, San Francisco , , , ...
... , PRINCETON, N.J. , May 10 ... the Company), a late-stage biotechnology company, announced today that ... of Treating Inflammatory Disorders of the Gastrointestinal Tract using ... the use of topically active corticosteroids in orally administered ...
... ... its revolutionary Trusted LASIK Surgeons directory service and website at www.TrustedLASIKSurgeons.com ... their vision and find a highly qualified eye surgeon who can help ... LASIK Surgeons directory apart is a unique screening process ensuring that only ...
Cached Biology Technology:Orexigen(R) Therapeutics to Speak at Ninth Annual JMP Securities Research Conference 2Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders 2Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders 3Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders 4Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders 5Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 2Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 3Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 4Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 5Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 6Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 7Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 8Baltimore Eye Surgeon Dr. Anthony Kameen Joins Select Group of LASIK & Cataract Surgery Doctors at Trusted LASIK Surgeons 9
(Date:8/29/2014)... in German . ... natural nitrogen cycle on Earth and in biological wastewater ... to depend on nitrite as their source of energy. ... a microbiologist at the University of Vienna, has now ... alternative source of energy. The oxidation of hydrogen with ...
(Date:8/29/2014)... In a cell,s nucleus, chromosomal DNA is tightly ... amalgam biologists call chromatin. Until about two decades ... the mere packing material around which the glamorous ... developed a greater appreciation for how DNA/histone interactions ... multiple research institutions studying the sequence of the ...
(Date:8/28/2014)... free mobile app called TX Invasives is now available ... University of Texas at Austin for identifying harmful non-native ... Invasive species in the United States cause about $137 ... destroy agricultural crops, clog waterways, kill native plants and ... Invasives app for reporting where invasive species occur, we,re ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Mobile app makes ID of harmful plants, insects in Texas a snap 2
... ( T. gondii ) is considered as one of the ... wide range of intermediate hosts, including all mammals and birds. ... and 20% in the world are chronically infected. ... now accepting applications for its Investigative Workshop, Modeling Toxoplasma ...
... have identified a gene they say is a strong ... other maladies associated with the natural flux in hormones ... in the Proceedings of the National Academy of ... showing that a common human variant of the gene ...
... , Feb. 9 Pacific Biomarkers, Inc. (OTC ... support pharmaceutical and laboratory diagnostic manufacturers in the conduct of ... investor conference call for 11:15 a.m. EST ( ... to review the Company,s operating results for the second ...
Cached Biology News:Modeling Toxoplasma focus of workshop 2Research identifies gene with likely role in premenstrual disorder 2Research identifies gene with likely role in premenstrual disorder 3Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010 2
... cells (BTI-TN-5B1-4) derived from Trichoplusia ni ... to be capable of expressing significantly ... compared to other insect cells. High ... doubling time as adherent cultures- Quick adaptation ...
... steadylite plus assay system offers ... sensitivity, Designed for batch-processing systems, ... higher density microplates such as ... free, Convenient storage conditions ( ...
... lysis buffer, PCR mix, DNA polymerase and ... volume PCR reactions. This system can detect ... rod and coccus bacteria, such as Escherichia ... Streptococcus Agalactiae, and etc. With the powerful ...
... Kit is uniquely formulated to give ... protein modification for optimal mass spectrometry ... with traditional silver stains are eliminated ... reagents used do not modify protein ...
Biology Products: